301 filings
SC 13G/A
ARDS
Aridis Pharmaceuticals, Inc.
14 Feb 24
Aridis Pharmaceuticals / ARMISTICE CAPITAL ownership change
2:21pm
SC 13G/A
Lind Global Fund II LP
13 Feb 24
Aridis Pharmaceuticals / Lind Global Fund II ownership change
8:02pm
8-K
ARDS
Aridis Pharmaceuticals, Inc.
16 Jan 24
Submission of Matters to a Vote of Security Holders
6:05am
DEFA14A
ARDS
Aridis Pharmaceuticals, Inc.
18 Dec 23
Additional proxy soliciting materials
9:43am
8-K
ARDS
Aridis Pharmaceuticals, Inc.
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
9:40am
DEFA14A
ARDS
Aridis Pharmaceuticals, Inc.
15 Dec 23
Additional proxy soliciting materials
5:00pm
10-Q
2023 Q3
ARDS
Aridis Pharmaceuticals, Inc.
Quarterly report
6 Nov 23
4:06pm
8-K
ARDS
Aridis Pharmaceuticals, Inc.
3 Nov 23
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results
5:00pm
DEFA14A
ARDS
Aridis Pharmaceuticals, Inc.
3 Nov 23
Additional proxy soliciting materials
6:15am
ARS
2022 FY
ARDS
Aridis Pharmaceuticals, Inc.
2 Nov 23
Annual report to shareholders
5:54pm
DEF 14A
ARDS
Aridis Pharmaceuticals, Inc.
Definitive proxy
2 Nov 23
5:51pm
4
ARDS
Aridis Pharmaceuticals, Inc.
19 Sep 23
Aridis Pharmaceuticals / JOHN F HAMILTON ownership change
4:05pm
4
Susan Richards Windham-Bannister
19 Sep 23
Aridis Pharmaceuticals / Susan Richards Windham-Bannister ownership change
4:05pm
4
Eric Patzer
19 Sep 23
Aridis Pharmaceuticals / Eric Patzer ownership change
4:05pm
4
ARDS
Aridis Pharmaceuticals, Inc.
19 Sep 23
Aridis Pharmaceuticals / Vu Truong ownership change
4:05pm
4
Hasan Jafri
19 Sep 23
Aridis Pharmaceuticals / Hasan Jafri ownership change
4:05pm
10-Q
2023 Q2
ARDS
Aridis Pharmaceuticals, Inc.
Quarterly report
13 Sep 23
9:47pm
25-NSE
ARDS
Aridis Pharmaceuticals, Inc.
8 Sep 23
Exchange delisting
10:13am
8-K
ARDS
Aridis Pharmaceuticals, Inc.
7 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
ARDS
Aridis Pharmaceuticals, Inc.
25 Aug 23
Termination of a Material Definitive Agreement
4:05pm